COSMED - ROOT ENGLISH

COSMED introduces BOD POD GS-X, the 4th generation of the world’s first and only Air Displacement Plethysmograph (ADP), the Gold Standard for two compartment Body Composition model. COSMED, world-wide leader manufacturer of Cardiopulmonary, Metabolic and Body Composition diagnostic equipment for clinical and human performance applications, announced today the release of BOD POD GS-X, a new...

COSMED wins the award "Best company on stage", the recognition delivered every year by Campus Bio-Medico University in Rome to those companies that have made possible a positive collaboration with the University for welcoming the largest number of trainees. "The idea is to give recognition to those who help us to complete our training course with an internship", explains Roberto...

Progetto Q-NRG INT-P Cofinanziato dall'Unione Europea - www.europa.eu Avviso Pubblico “Voucher Internazionalizzazione” di cui alla Det. n. G10195 del 26/07/2019 - POR FESR LAZIO 2014-2020 – CUP F14E20000090007 – Domanda prot. n. A0331-2019-31351 Progetto approvato con Determinazione n. G02590 del 06/03/2020 pubblicata sul BURL n. 23 del 10/03/2020 Titolo del progetto: “Q-NRG...

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max). Innovision’s products are a perfect match to...

The FDA has granted marketing approval for the device in the US market where we expect to launch the product during the next ASPEN 2020 Nutrition conference taking place in Tampa, FL on March 28-31. Q-NRG is a result of COSMED’s collaboration with world-class institutes in the field of nutrition support in intensive care units. Product concept and specifications have been designed together...

More Articles …

CONTACT US

CONTACT US

SUPPORT

SUPPORT

FOLLOW US ON

FOLLOW US ON